| Year |
Citation |
Score |
| 2010 |
Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, Diehl JA, Herlyn M, Han M, Nakagawa H, Rustgi AK. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proceedings of the National Academy of Sciences of the United States of America. 107: 11026-31. PMID 20534479 DOI: 10.1073/Pnas.0914295107 |
0.451 |
|
| 2010 |
Michaylira CZ, Wong GS, Miller CG, Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim SB, Herlyn M, Diehl JA, Gimotty P, Rustgi AK. Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. Cancer Research. 70: 5281-92. PMID 20516120 DOI: 10.1158/0008-5472.Can-10-0704 |
0.35 |
|
| 2010 |
Lee JJ, Natsuizaka M, Ohashi S, Wong GS, Takaoka M, Michaylira CZ, Budo D, Tobias JW, Kanai M, Shirakawa Y, Naomoto Y, Klein-Szanto AJ, Haase VH, Nakagawa H. Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis. Carcinogenesis. 31: 427-34. PMID 20042640 DOI: 10.1093/Carcin/Bgp326 |
0.307 |
|
| 2010 |
Grugan KD, Miller CG, Michaylira CZ, Klein-Szanto AJ, Nakagawa H, Rustgi AK. Abstract 279: Increased Met receptor activation mediates enhanced cell invasion upon mutant p53 expression in esophageal squamous cell carcinoma Cancer Research. 70: 279-279. DOI: 10.1158/1538-7445.Am10-279 |
0.348 |
|
| 2009 |
Lim DM, Narasimhan S, Michaylira CZ, Wang ML. TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 297: G1172-80. PMID 19779021 DOI: 10.1152/Ajpgi.00065.2009 |
0.343 |
|
| 2009 |
Wilkey JF, Buchberger G, Saucier K, Patel SM, Eisenberg E, Nakagawa H, Michaylira CZ, Rustgi AK, Mallya SM. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Molecular Carcinogenesis. 48: 853-61. PMID 19263437 DOI: 10.1002/Mc.20531 |
0.394 |
|
| 2009 |
Lim DM, Lombardi LA, Michaylira CZ, Rustgi AK, Wang M. 179 Functional Characterization of Toll-Like Receptor 3 Signaling in Human Esophageal Keratinocytes Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)60150-5 |
0.474 |
|
| 2008 |
Kalabis J, Oyama K, Okawa T, Nakagawa H, Michaylira CZ, Stairs DB, Figueiredo JL, Mahmood U, Diehl JA, Herlyn M, Rustgi AK. A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. The Journal of Clinical Investigation. 118: 3860-9. PMID 19033657 DOI: 10.1172/Jci35012 |
0.339 |
|
| 2008 |
Yang Y, Stairs DB, Michaylira CZ, Lee JJ, Kalabis J, Grugan KD, Andl CD, Budo D, Pear WS, Katz JP, Rustgi AK, Nakagawa H. M2010 Notch Signaling Regulates Esophageal Epithelial Homeostasis and Tumor Progression Gastroenterology. 134: A-450. DOI: 10.1016/S0016-5085(08)62103-4 |
0.314 |
|
| 2007 |
Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E, Herlyn M, Rustgi AK. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes & Development. 21: 2788-803. PMID 17974918 DOI: 10.1101/Gad.1544507 |
0.383 |
|
| 2007 |
Takaoka M, Kim SH, Okawa T, Michaylira CZ, Stairs DB, Johnstone CN, Andl CD, Rhoades B, Lee JJ, Klein-Szanto AJ, El-Deiry WS, Nakagawa H. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biology & Therapy. 6: 534-40. PMID 17457048 DOI: 10.4161/Cbt.6.4.3832 |
0.56 |
|
| 2006 |
Michaylira CZ, Nakagawa H. Hypoxic microenvironment as a cradle for melanoma development and progression. Cancer Biology & Therapy. 5: 476-9. PMID 16627974 DOI: 10.4161/Cbt.5.5.2749 |
0.346 |
|
| 2006 |
Michaylira CZ, Simmons JG, Ramocki NM, Scull BP, McNaughton KK, Fuller CR, Lund PK. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. American Journal of Physiology. Gastrointestinal and Liver Physiology. 291: G472-81. PMID 16574995 DOI: 10.1152/Ajpgi.00218.2005 |
0.609 |
|
| 2006 |
Michaylira CZ, Ramocki NM, Simmons JG, Tanner CK, McNaughton KK, Woosley JT, Greenhalgh CJ, Lund PK. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice. Endocrinology. 147: 1632-41. PMID 16410303 DOI: 10.1210/En.2005-1241 |
0.599 |
|
| 2005 |
Fruchtman S, Simmons JG, Michaylira CZ, Miller ME, Greenhalgh CJ, Ney DM, Lund PK. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 289: G342-50. PMID 15831713 DOI: 10.1152/Ajpgi.00413.2004 |
0.72 |
|
| 2004 |
Miller ME, Michaylira CZ, Simmons JG, Ney DM, Dahly EM, Heath JK, Lund PK. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology. 127: 570-81. PMID 15300589 DOI: 10.1053/J.Gastro.2004.05.016 |
0.742 |
|
| Show low-probability matches. |